E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/5/2019 in the Prospect News Bank Loan Daily.

Confluent talks $200 million term loan at Libor plus 475-500 bps

By Sara Rosenberg

New York, June 5 – Confluent Health LLC launched on Wednesday its $200 million seven-year covenant-lite first-lien term loan (B3/B-) with price talk of Libor plus 475 basis points to 500 bps with a 0% Libor floor and an original issue discount of 99, according to a market source.

The term loan has 101 soft call protection for six months.

Deutsche Bank Securities Inc., Macquarie Capital (USA) Inc. and Bank of Ireland are the bookrunners on the deal.

Commitments are due at noon ET on June 17, the source added.

Proceeds will be used to help support a significant equity investment in the company by Partners Group on behalf of its clients alongside management. The Edgewater Funds will divest its holding in the company as part of the transaction.

Confluent Health is a Louisville, Ky.-based outpatient physical therapy provider.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.